Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study

Background: Agomelatine is a melatonin agonist and 5HT antagonist developed for the treatment of major depressive disorder which also has some effects on the circadian system. Since circadian dysfunctions are thought to play a role in the pathophysiology of depression, some of the mechanism of actio...

Descripción completa

Detalles Bibliográficos
Autores principales: Robillard, Rebecca, Carpenter, Joanne S., Feilds, Kristy-Lee, Hermens, Daniel F., White, Django, Naismith, Sharon L., Bartlett, Delwyn, Whitwell, Bradley, Southan, James, Scott, Elizabeth M., Hickie, Ian B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297866/
https://www.ncbi.nlm.nih.gov/pubmed/30618853
http://dx.doi.org/10.3389/fpsyt.2018.00624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297866/
https://www.ncbi.nlm.nih.gov/pubmed/30618853
http://dx.doi.org/10.3389/fpsyt.2018.00624

Ejemplares similares